Evidence map›Paper›PMID 32545485›Full record

ReviewJournal of fungi (Basel, Switzerland)2020

Clinical Relevance and Characteristics of

Emmanouil Glampedakis, Véronique Erard, Frederic Lamoth

Open access · goldAbstract readReview
In one paragraph

Review in Journal of fungi (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.2field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Successful salvage treatment ofMedical mycology case reports · 2026
    Article
  2. A breakthrough invasiveMedical mycology case reports · 2026
    Article
  3. Article
  4. BeyondAntimicrobial agents and chemotherapy · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Pulmonary aspergillosis: diagnosis and treatment.European respiratory review : an official journal of the European Respiratory Society · 2022
    Article
  11. Article
  12. Article
  13. Pathogens (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Emmanouil GlampedakisInfectious Diseases Service, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
Véronique ErardClinique de Médecine et spécialités, Infectiologie, HFR-Fribourg, 1708 Fribourg, Switzerland.
Frederic LamothInfectious Diseases Service, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
University of Lausanne · CHFribourg Development Agency · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The

Indexed as

Aspergillus granulosusAspergillus insuetusAspergillus keveiiAspergillus pseudodeflectusAspergillus puniceusAspergillus ustusinvasive aspergillosis

Identifiers

PMID32545485
PMCPMC7344933
OpenAlexW3035710540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.